Principal Investigator: Professor Stephen Sawcer
Department: Clinical Neurosciences
Institution: University of Cambridge
Lead collaborator –
Professor Bernhard Hemmer, Technische Universitat Munchen, GermanyTags: 6728, Association, Autoimmunity, genetics, GWAS, UK
1a: Autoimmune diseases, such as multiple sclerosis, type 1 diabetes, coeliac disease, rheumatoid arthritis, lupus and thyroid disease, are common health problems in the UK. Comparing and contrasting the results from disease specific GenomeWide Association Studies (GWAS) has shown that there are common aetiological mechanisms underlying these diseases and in this context we are proposing to undertake a GWAS with autoimmunity as the primary endpoint using genotype data from the UK Biobank as controls. Each disease specific group in this collaborative application has genotype data from many thousands of affected UK individuals. Imputation will enable us to compare these existing data
1b: with UK Biobank subjects. To supplement these already extensive existing data we will be applying for funding to undertake genotyping of the UK Biobank chip in several thousand previously untested cases. This GWAS would be well powered to identify even low frequency risk variants. The results generated might provide invaluable insight into aetiology and thereby enhance the potential development of safe, effective, rational therapies.
The main analysis would exclude those participants with self-reported autoimmune disease at baseline. Further analyses would be done using self-reported cases and controls from UK Biobank in combination with data from other studies. Disease specific analysis will
1c: also be performed with similar treatment of the relevant self reported cases. It is anticipated that most if not all of the untyped UK autoimmune disease patients are not currently part of UK Biobank.
1d: Full Cohort
Last updated Mar 2, 2020